FRANCISCO TREJO: Open Payments
NPI 1508866005 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,316 in 65 payments from 10 companies in 2025. Trend: 2023 $989 · 2024 $965 · 2025 $1,316
Food & beverage: $1,216Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 9 | $313 |
| Incyte Corporation | 23 | $310 |
| Lilly USA, LLC | 11 | $252 |
| ABBVIE INC. | 13 | $159 |
| Regeneron Healthcare Solutions, Inc. | 2 | $101 |
| LEO Pharma Inc. | 1 | $70 |
| Amgen Inc. | 2 | $34 |
| Galderma Laboratories, L.P. | 2 | $29 |
| Novartis Pharmaceuticals Corporation | 1 | $24 |
| GENZYME CORPORATION | 1 | $24 |
Products named: TREMFYA, OPZELURA, TALTZ, SKYRIZI, DUPIXENT, EBGLYSS, ADBRY, OTEZLA.
Industry payments across AZ — which companies pay providers there.
